Our group studies γδ T cells in cancer and how to optimise them for cellular immunotherapy. Based at the Department of Clinical Immunology, Medical University of Lublin, the group is led by Prof. Michał Zarobkiewicz.
Team
-
Prof. Michał Zarobkiewicz
Team leader
-
Natalia Lehman, MD
Researcher
-
Adam Michalski, MD
Doctoral student
Funded projects
-
2020–2025
Interactions between γδ T lymphocytes and M-MDSC cells in the pathogenesis of chronic lymphocytic leukemia
National Science Centre, Poland
2019/35/N/NZ6/02973 -
2023–2024
Modern drugs in the treatment of chronic lymphocytic leukemia – impact on γδ T lymphocytes
Medical University of Lublin
PBmn 161 -
2023–2025
Impact of selected BTK inhibitors on γδ T cells and γδ T immunotherapy
DKMS Foundation
-
2023–2024
γδ T lymphocytes in type II diabetes mellitus and their therapeutic potential
Ministry of Higher Education and Science
MNiE SKN/SP/570637/2023


